The effect of pioglitazone on circulating interleukin-10 and tumor necrosis factor-alpha levels in a patient with metabolic syndrome: A randomized, double-blind controlled trial. [electronic resource]
- ARYA atherosclerosis Jan 2015
- 36-42 p. digital